印度“毒糖浆”疑致多名儿童死亡，警方逮捕涉事企业老板

Group 1 - The owner of the pharmaceutical company "Sreyas Pharmaceuticals," Rangnathan, has been arrested in connection with cough syrup linked to the deaths of at least 21 children under the age of five in Madhya Pradesh [1] - The cough syrup produced by Sreyas Pharmaceuticals was found to contain diethylene glycol at levels nearly 500 times above the permissible limit, which can cause severe health issues including vomiting, abdominal pain, and acute kidney injury [1] - The Indian government has intensified actions to control the circulation of contaminated medicines, including random sampling of cough syrups and house-to-house collection of the affected syrup bottles [1] Group 2 - The World Health Organization has highlighted regulatory gaps in India's pharmaceutical sector and has warned that some affected products may be exported through informal channels [1] - The cough syrup in question is reported to have been sold only within India, but the WHO is seeking clarification from the Indian government regarding potential exports to other countries [2] - Indian pharmaceuticals are a significant export to developing countries, with the contaminated cough syrup linked to over 140 child deaths in countries such as Gambia, Uzbekistan, and Cameroon [2]